// App-Quantinova.ai

PB0340 : Treatment by Line in Patients With Persistent and Chronic Immune Thrombocytopenia, A Real-World Point-In-Time Study

Researchers

Presenter

  • M. Cooney

Principal Investigators

  • S. Chang

  • K. Lewis

Medical Centers

  • UCB Pharma, Morrisville, North Carolina, United States

  • UCB Pharma, Atlanta, Georgia, United States

  • UCLouvain, Brussels, Brussels Hoofdstedelijk Gewest, Belgium

  • UCB Pharma, Monheim, Nordrhein-Westfalen, Germany

  • Adelphi Real World, Bollington, United Kingdom

  • UCB Pharma, Breda, Noord-Brabant, Netherlands

Locations

  • United States

  • Belgium

  • Germany

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • UCB

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved